Publications by authors named "Anna Gambaro"

Claim this Profile
R
Rising Concern About the Carcinogenetic Role of Micro-Nanoplastics.
Lorenzo Ruggieri, Ottavia Amato, Cristina Marrazzo, Manuela Nebuloni, Davide Dalu, Anna Gambaro

Int J Mol Sci· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contrast Enhancement in Breast Cancer: Magnetic Resonance vs. Mammography: A 10-Year Systematic Review.
Francesco Filippone, Zohra Boudagga, Francesca Frattini, Gaetano Federico Fortuna, Davide Razzini, Anna Clelia Lucia Gambaro

Diagnostics (Basel)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the impact of delayed-phase imaging in Contrast-Enhanced Mammography on breast cancer staging: A comparative study of abbreviated versus complete protocol.
Naomi Calabrò, Flavia Abruzzese, Eleonora Valentini, Anna Clelia Lucia Gambaro, Silvia Attanasio

Radiol Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hospital-Based Influenza and Pneumococcal Vaccination for Cancer Patients on Active Treatment and Their Family Members during the COVID-19 Pandemic in Italy: A Single-Center Experience.
Davide Dalu, Anna Lisa Ridolfo, Lorenzo Ruggieri, Maria Silvia Cona, Agostino Riva, Anna Gambaro

Vaccines (Basel)· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody response to three-dose anti-SARS-CoV-2 mRNA-vaccination in treated solid cancer patients.
Davide Dalu, Maciej Tarkowski, Lorenzo Ruggieri, Maria Silvia Cona, Arianna Gabrieli, Anna Gambaro

Int J Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Locoregional staging of breast cancer: contrast-enhanced mammography versus breast magnetic resonance imaging.
Andrea Terzoni, Paola Basile, Anna Clelia Gambaro, Silvia Attanasio, Anna Maria Rampi

Radiol Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpelisib for PIK3CA-mutated advanced gynecological cancers: First clues of clinical activity.
Anna Passarelli, Vittoria Carbone, Sandro Pignata, Roberta Mazzeo, Domenica Lorusso, Anna Rita Gambaro

Gynecol Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mammary nodules as incidental findings on chest computed tomography: a retrospective analysis on their frequency and predictive value.
Maria Francesca Agliata, Naomi Calabrò, Stefano Tricca, Anna Maria Rampi, Anna Clelia Lucia Gambaro

Radiol Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical efficacy of the first two doses of anti-SARS-CoV-2 mRNA vaccines in solid cancer patients.
Maria Silvia Cona, Agostino Riva, Davide Dalu, Arianna Gabrieli, Cinzia Fasola, Anna Gambaro

Cancer Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from , a multicentric, observational study.
Francesca Sofia Di Lisa, Eriseld Krasniqi, Laura Pizzuti, Maddalena Barba, Katia Cannita, Anna Rita Gambaro

Front Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Host-Related Factors in the Interplay among Inflammation, Immunity and Dormancy in Breast Cancer Recurrence and Prognosis: An Overview for Clinicians.
Lorenzo Ruggieri, Anna Moretti, Rossana Berardi, Maria Silvia Cona, Davide Dalu, Anna Gambaro

Int J Mol Sci· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of two doses of BNT162b2 and mRNA-1273 vaccines for solid cancer patients on treatment with or without a previous SARS-CoV-2 infection.
Nicla La Verde, Agostino Riva, Maria Silvia Cona, Arianna Gabrieli, Monica Cattaneo, Anna Gambaro

Int J Cancer· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer and communication: monocentric experience of a self-assessment questionnaire.
Vittorio Longo, Flavia Abruzzese, Vittoria Miserocchi, Serena Carriero, Anna Clelia Gambaro

J Public Health Res· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The emotional impact of the COVID-19 outbreak on cancer outpatients and their caregivers: results of a survey conducted in the midst of the Italian pandemic.
Maria Silvia Cona, Eliana Rulli, Davide Dalu, Francesca Galli, Selene Rota, Anna Gambaro

Support Care Cancer· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fulvestrant and trastuzumab in patients with luminal HER2-positive advanced breast cancer (ABC): an Italian real-world experience (HERMIONE 9).
Rosalba Torrisi, Raffaella Palumbo, Rita De Sanctis, Patrizia Vici, Giulia Valeria Bianchi, Anna Rita Gambaro

Breast Cancer Res Treat· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pegylated liposomal doxorubicin as first line treatment in aids-related Kaposi's sarcoma: a real-life study.
Davide Dalu, Cinzia Fasola, Luca Ammoni, Davide De Francesco, Maria Silvia Cona, Anna Gambaro

J Chemother· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single nucleotide polymorphisms to predict taxanes toxicities and effectiveness in cancer patients.
Sara Demurtas, Nicla La Verde, Selene Rota, Giovanni Casazza, Cristina Montrasio, Anna Gambaro

Pharmacogenomics J· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A proposal of a "ready to use" COVID-19 control strategy in an Oncology ward: Utopia or reality?
Davide Dalu, Selene Rota, Maria Silvia Cona, Anna Maria Brambilla, Sabrina Ferrario, Anna Gambaro

Crit Rev Oncol Hematol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial.
Maria Vittoria Dieci, Giancarlo Bisagni, Alba A Brandes, Antonio Frassoldati, Luigi Cavanna, Anna Rita Gambaro

BMC Med· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of treatment and outcome with 500-mg fulvestrant in postmenopausal women with hormone receptor-positive/HER2-negative metastatic breast cancer: a real-life multicenter Italian experience.
Raffaella Palumbo, Federico Sottotetti, Erica Quaquarini, Anna Gambaro, Antonella Ferzi

Ther Adv Med Oncol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ABCB1 c.3435C>T polymorphism is associated with platinum toxicity: a preliminary study.
Beatrice De Troia, Davide Dalu, Virginio Filipazzi, Luigi Isabella, Nicoletta Tosca, Anna Rita Gambaro

Cancer Chemother Pharmacol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nab-Paclitaxel in Advanced HER2-negative Breast Cancer Patients: Efficacy and Safety Beyond Clinical Trials.
Antonio Bernardo, Raffaella Palumbo, Rebecca Pedersini, Elena Rota Caremoli, Anna Rita Gambaro

Clin Breast Cancer· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A targeted approach to genetic counseling in breast cancer patients: the experience of an Italian local project.
Nicla La Verde, Fabio Corsi, Anna Moretti, Bernard Peissel, Davide Dalu, Anna Gambaro

Tumori· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: prospective evaluation of activity, safety, and quality of life.
Raffaella Palumbo, Federico Sottotetti, Giuseppe Trifirò, Elena Piazza, Antonella Ferzi, Anna Gambaro

Drug Des Devel Ther· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of bullous dermatitis induced by erlotinib.
Alessandro Oteri, Maria Teresa Cattaneo, Virginio Filipazzi, Sabrina Ferrario, Anna Gambaro

Oncologist· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis